Opendata, web and dolomites

Cell2Cell SIGNED

What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Cell2Cell project word cloud

Explore the words cloud of the Cell2Cell project. It provides you a very rough idea of what is the project "Cell2Cell" about.

little    cancer    outcome    chromatin    prepared    bioinformatics    plays    changing    decrease    variability    challenged    organization    establishment    people    environments    cell    population    individual    immune    academia    infectious    modern    adapt    organisms    decades    biology    understand    epigenetic    give    molecular    species    revealed    genome    multicellular    renders    previously    kill    tools    pathogens    burden    employ    insights    dna    hypothesized    limitations    degree    noise    successful    stage    skilled    small    enormous    models    started    infection    host    diseases    evade    size    structural    phenotypic    cellular    infections    train    enabled    overcome    proposes    establishing    microbial    scientists    unveiling    single    revolutionize    yeast    mechanisms    sequence    cell2cell    unicellular    experts    worldwide    millions    demands    industry    plasticity    barriers    pathogen    signal    serve    lack    genomics    developmental    lasting    technologies    endeavor    genetic    elucidation    of    heterogeneity    caused   

Project "Cell2Cell" data sheet

The following table provides information about the project.

Coordinator
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

Organization address
address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539
website: www.uni-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 3˙889˙769 €
 EC max contribution 3˙889˙769 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 1˙011˙153.00
2    HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH DE (NEUHERBERG) participant 505˙576.00
3    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 303˙172.00
4    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 281˙982.00
5    SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT CH (Basel) participant 281˙276.00
6    INSTITUT CURIE FR (PARIS) participant 274˙802.00
7    STICHTING KATHOLIEKE UNIVERSITEIT NL (NIJMEGEN) participant 265˙619.00
8    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) participant 263˙500.00
9    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) participant 237˙720.00
10    EPIGENETIKS GENETIK BIYOINFORMATIK YAZILIM AS TR (ISTANBUL) participant 235˙248.00
11    CELLSORTER MUSZAKI KUTATO ES FEJLESZTO KFT HU (BUDAPEST) participant 229˙715.00

Map

 Project objective

Infectious diseases kill millions of people worldwide every year. Decades of research have revealed important insights into the molecular mechanisms pathogens employ to establish lasting infections, yet little is known about what renders individual pathogens within a microbial population more successful at establishing an infection than others. Recent advances in single-cell technologies have started to revolutionize modern biology, unveiling an enormous degree of cell-to-cell heterogeneity. Often, phenotypic variability is not caused by genetic changes in the DNA sequence, but by epigenetic changes in the structural organization of DNA called chromatin. In multicellular organisms, this epigenetic plasticity plays a key role in developmental processes and cancer. In unicellular pathogens, cell-to-cell heterogeneity is hypothesized to promote the establishment of infections by allowing the pathogen to adapt to changing environments or evade the host immune response. To decrease the burden of infectious diseases, it is therefore, necessary to better understand how infections are enabled by cellular heterogeneity at the chromatin level of the pathogen. Several limitations have previously challenged this endeavor, including small genome size (i.e. low signal-to-noise) and the lack of knowledge of how chromatin is organized in pathogens. Cell2Cell proposes to overcome these barriers by bringing together (1) experts in pathogen biology; (2) the use of unicellular yeast species to serve as chromatin models; (3) single-cell technologies; (4) bioinformatics tools. Using state of the art technologies, we will train early stage researchers to identify the molecular mechanisms that control cell-to-cell heterogeneity in pathogens. The proposed research will contribute to the elucidation of how heterogeneity affects the outcome of diseases and give rise to highly skilled scientists that are well prepared to face the demands of modern genomics research in academia and industry.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CELL2CELL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CELL2CELL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

WON (2019)

Wideband Optical Networks

Read More